205 related articles for article (PubMed ID: 32688070)
1. The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
Trexler KR; Vanegas SO; Poklis JL; Kinsey SG
Drug Alcohol Depend; 2020 Sep; 214():108179. PubMed ID: 32688070
[TBL] [Abstract][Full Text] [Related]
2. Assessment of dependence potential and abuse liability of Δ
Vanegas SO; Reck AM; Rodriguez CE; Marusich JA; Yassin O; Sotzing G; Wiley JL; Kinsey SG
Drug Alcohol Depend; 2022 Nov; 240():109640. PubMed ID: 36179506
[TBL] [Abstract][Full Text] [Related]
3. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
Wilson CD; Hiranita T; Fantegrossi WE
Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
[TBL] [Abstract][Full Text] [Related]
4. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
5. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.
Trexler KR; Nass SR; Crowe MS; Gross JD; Jones MS; McKitrick AW; Siderovski DP; Kinsey SG
Drug Alcohol Depend; 2018 Oct; 191():14-24. PubMed ID: 30071445
[TBL] [Abstract][Full Text] [Related]
6. CB
Trexler KR; Eckard ML; Kinsey SG
Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
Tai S; Nikas SP; Shukla VG; Vemuri K; Makriyannis A; Järbe TU
Psychopharmacology (Berl); 2015 Aug; 232(15):2751-61. PubMed ID: 25772338
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
9. Differential disruption of response alternation by precipitated Δ
Eckard ML; Kinsey SG
Pharmacol Biochem Behav; 2024 Mar; 236():173718. PubMed ID: 38272272
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
[TBL] [Abstract][Full Text] [Related]
12. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
[TBL] [Abstract][Full Text] [Related]
13. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
14. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
Huang P; Liu-Chen LY; Unterwald EM; Cowan A
Neurosci Lett; 2009 Nov; 465(1):66-70. PubMed ID: 19733208
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.
Eckard ML; Kinsey SG
Neuropharmacology; 2021 Jun; 190():108554. PubMed ID: 33845073
[TBL] [Abstract][Full Text] [Related]
17. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
19. Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.
Oliveira da Cruz JF; Ioannidou C; Pagano Zottola AC; Muguruza C; Gomez-Sotres P; Fernandez M; Callado LF; Marsicano G; Busquets-Garcia A
Addict Biol; 2021 May; 26(3):e12940. PubMed ID: 32744799
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497.
Grim TW; Samano KL; Ignatowska-Jankowska B; Tao Q; Sim-Selly LJ; Selley DE; Wise LE; Poklis A; Lichtman AH
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):217-28. PubMed ID: 27149200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]